SEAVI Advent is a private equity and venture capital firm founded in 1984, making it the first of its kind in Southeast Asia. Headquartered in Singapore, with additional offices in Hong Kong and Shanghai, the firm specializes in growth capital investments across various industries, including business services, communications, consumer-related sectors, media, healthcare, and technology. SEAVI Advent primarily targets equity and debt investments in high-growth, profitable companies, focusing on regions such as Southeast Asia, Asia Pacific, and Greater China. The firm typically invests between $5 million and $25 million in companies with an enterprise value ranging from $25 million to $100 million. Additionally, SEAVI Advent prefers to take board seats in its portfolio companies to provide strategic oversight and guidance. As the Asian affiliate of Advent International Corporation, it benefits from a vast network and extensive experience within the global private equity landscape.
1 Coleman Street #07-02A The Adelphi, Singapore 179803
Kevin Chan
Partner
Lau Yui Chan
Partner
Hoe Boon Kwee
Partner and Chief Financial Officer
Derrick Lee
Managing Partner
Yong Wah Ling
Partner
Wee Kee Lua
Investment Professional
Keng Boon Tan
Managing Partner and Chief Executive Officer
1 past transactions
Sinocom Pharmaceutical
Series A in 2009
Sinocom Pharmaceutical, Inc., a pharmaceutical company, grows and sells natural herbs in the People's Republic of China. The company also sells various third party traditional Chinese medicine formulated products and western medicines. Its pharmaceutical products include over-the-counter and prescription pharmaceuticals. The company sells its products to hospitals, medical clinics, drug stores, and distributors. Sinocom Pharmaceutical, Inc. was founded in 1997 and is based in Central, Hong Kong.